DUBLIN–(BUSINESS WIRE)–The “Phoropters Market – Growth, Trends, and Forecast (2020-2025)” report has been added to ResearchAndMarkets.com’s offering. The global Phoropters market is anticipated to grow with a CAGR of nearly 4.1%, during the forecast …
Author: Business Wire
Global Dry Eye Products Market Forecast to 2027 – COVID-19 Impact and Analysis by Product, Type and Geography – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Products Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product; Type, and Geography” report has been added to ResearchAndMarkets.com’s offering. Market for Hormone Drops to Grow at the Highest CA…
Riassunto: Enspryng (Satralizumab) di Chugai riceve l’omologazione dalla FDA per il disturbo dello spettro neuromielite ottica
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) ha annunciato in data odierna che l’ente statunitense preposto al controllo dei farmaci e degli alimenti (Food and Drug Administration, FDA) ha concesso la designazione di terapia inn…
Chugai’s Enspryng (Satralizumab) Receives Regulatory Approval from FDA for Neuromyelitis Optica Spectrum Disorder
TOKYO–(BUSINESS WIRE)– #NMOSD–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the U.S. Food and Drug Administration (FDA) has approved the pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody, Enspryng™ (US generic name…
FDA Approves Genentech’s Enspryng for Neuromyelitis Optica Spectrum Disorder
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Enspryng™ (satralizumab-mwge) as the first and only subcuta…
Global Personalized LASIK Surgery Market 2020-2025: Data for Myopia, Hypermetropia, Presbyopia and Other Indications – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Personalized LASIK Surgery Market – Growth, Trends, and Forecasts (2020-2025)” report has been added to ResearchAndMarkets.com’s offering. Certain factors that are driving the market growth include growing demand for laser…
Global Two-photon Laser Scanning Confocal Microscope Market to 2024 – Increase in Applications in Life Science Research is Driving the Industry – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Two-photon Laser Scanning Confocal Microscope Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The two-photon laser scanning confocal microscope market is poised to grow by $ 216.69 mn d…
Avellino Hits the 1-Million Genetic Test Milestone
MENLO PARK, Calif.–(BUSINESS WIRE)– #avagen–Avellino announces milestone of performing over 1-million of their genetic and molecular diagnostic tests, including more than 180,000 COVID-19 tests.
Gyroscope Therapeutics Announces Initiation of Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular Degeneration
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope announces initiation of Phase II programme evaluating its investigational gene therapy, GT005, for dry age-related macular degeneration.
VisionQuest Biomedical’s EyeStar Passes the 30,000-Patient Milestone for Diabetic Retinopathy Screening Using Artificial Intelligence
ALBUQUERQUE, N.M.–(BUSINESS WIRE)– #ai–VisionQuest Biomedical Inc. announces that the company has screened over 30,000 patients for diabetic retinopathy at the Clínicas del Azúcar in Mexico using the EyeStar artificial intelligence (AI) software. Th…
WaveFront Dynamics Names Jeff Kolberg as New Chief Commercial Officer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics, today announced that Jeff Kolberg has been appointed as the company’s Chief Commercial Officer.
New Canadian Brand KITS Set to Disrupt the Eyewear Industry With Launch of Direct-to-Consumer Designer Eyewear Brand
VANCOUVER, British Columbia–(BUSINESS WIRE)–KITS, Canada’s fastest growing eyewear brand is today launching its revolutionary platform KITS.com. Led by a team of industry veterans, KITS is backed by over 70 years of combined experience culminating in…
Global Soft Contact Lens Market (2020 to 2024) – Featuring Menicon, Novartis & SEED Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Soft Contact Lens Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The soft contact lens market is poised to grow by $ 1.71 bn during 2020-2024 progressing at a CAGR of 3% during the for…
Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights
VICTORIA, British Columbia–(BUSINESS WIRE)–AURINIA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS
Stanton Optical and My Eyelab’s Affiliated Network of Doctors Providing Free Eye Exams for Kids in August
PALM SPRINGS, Fla.–(BUSINESS WIRE)–Stanton Optical and My Eyelab, leading retail brands of Now Optics offering accessible and affordable eye care and eyewear, and their affiliated network of doctors, are kicking off National Eye Exam Month and back t…
Insights on the Global Ophthalmology PACS Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOphthalmologyPACSMarket–The Global Ophthalmology PACS Market will grow by USD 59.9 mn during 2020-2024
Eyenuk、糖尿病網膜症スクリーニング用のEyeArt自律的AIシステムに対するFDA認可の取得を発表
ロサンゼルス–(BUSINESS WIRE)–（ビジネスワイヤ） — 人工知能（AI）医療技術・サービスの世界的企業で、AIアイ・スクリーニング向け実臨床アプリケーションのリーダー企業のEyenuk, Inc.は本日、米国の成人における失明の主因となっている糖尿病網膜症に対する自律的AIシステムEyeArt®の上市につき、米国食品医薬品局（FDA）より510(k)認可（K200667）を取得したと発表しました。 EyeArtは、医療提供者が使用して、過去に軽度以上の糖尿病網膜症の診断を受けてい…
Eyenuk宣布FDA核准EyeArt自主AI系統用於糖尿病視網膜病變篩查
洛杉磯–(BUSINESS WIRE)–(美國商業資訊)–Eyenuk, Inc.是一家全球性人工智慧(AI)醫療技術和服務公司，是AI眼病篩檢真實世界應用的領導者，公司今天宣布，美國食品藥品管理局(FDA)已簽發該公司用於糖尿病視網膜病變的EyeArt®自主AI系統上市的510(k)核准(K200667)，該病變是美國成人失明的主要病因。 EyeArt適用於醫療保健提供者，對既往未診斷的輕度以上糖尿病視網膜病變成人眼的輕度以上糖尿病視網膜病變(mtmDR)和威脅視力的糖尿病視網膜病變(vtD…
Eyenuk宣布FDA核准EyeArt自主AI系统用于糖尿病视网膜病变筛查
洛杉矶–(BUSINESS WIRE)–(美国商业资讯)–Eyenuk, Inc.是一家全球性人工智能(AI)医疗技术和服务公司，是AI眼病筛查真实世界应用的领导者，公司今天宣布，美国食品药品管理局(FDA)已签发该公司用于糖尿病视网膜病变的EyeArt®自主AI系统上市的510(k)核准(K200667)，该病变是美国成人失明的主要病因。 EyeArt适用于医疗保健提供者，对既往未诊断的轻度以上糖尿病视网膜病变成人眼的轻度以上糖尿病视网膜病变(mtmDR)和威胁视力的糖尿病视网膜病变(vtD…
COVID-19 Impacts: Glaucoma Surgery Devices Market Will Accelerate at a CAGR of almost 31% through 2020-2024 | Increasing Prevalence of Glaucoma to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)– #GlaucomaSurgeryDevicesMarket–The Global Glaucoma Surgery Devices Market will grow by USD 1.53 bn during 2020-2024